Search the Newsreel

Astera Labs (ALAB) director Stefan Dyckerhoff sells 12,499 shares under 10b5-1 plan

Astera Labs director Stefan A. Dyckerhoff sold 12,499 shares of common stock on August 6, 2026, through multiple open-market transactions. These sales were conducted at weighted average prices between $309 and $313 per share, according to a Rule 10b5-1 trading plan established on December …

Blend Labs, Inc.'s (NYSE:BLND) Shift From Loss To Profit

What Makes Proto Labs (PRLB) a Strong Momentum Stock: Buy Now?

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …

Apogee Adds Joseph Hayek, Suresh Krishna to Board of Directors

Apogee Enterprises Inc. has expanded its board of directors from six to eight members by electing Joseph Hayek and Suresh Krishna as independent directors. Hayek is the president and CEO of Worthington Enterprises Inc., and Krishna is the president and CEO of Proto Labs …

VivoSim Labs (NASDAQ: VIVS) seeks approval for reverse split, warrant share issuance

VivoSim Labs (NASDAQ: VIVS) is seeking stockholder approval for several key proposals at its virtual 2026 annual meeting on September 30, 2026. These include electing Class III directors, ratifying their auditor, an advisory vote on executive compensation, and crucially, approving a board-discretionary reverse stock …

Proto Labs (PRLB) Lifts Outlook As Fair Value Looks Fully Valued

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$102

Establishment Labs Holdings Inc. (NASDAQ:ESTA) saw its stock drop 17% last week after releasing earnings, despite revenues beating expectations by 2.7%. Analysts have updated their forecasts, maintaining revenue estimates but increasing per-share loss expectations, yet they still raised the average price target by 7.1% …

Astera Labs, Inc. $ALAB Shares Sold by StoneCrest Wealth Management Inc.

StoneCrest Wealth Management Inc. significantly reduced its stake in Astera Labs (NASDAQ:ALAB) by 91.8% in the second quarter, selling 6,569 shares and retaining 584 shares valued at $282,000. Despite this, institutional investors collectively own 60.47% of ALAB, and the company reported strong Q2 earnings, …

Kwality Pharma, Aarti Pharmalabs, Universal Cables hit 20% upper circuits

Aarti Pharmalabs Q1 Results: Consolidated Net Profit Rises 65% YoY

Royal Bank of Canada Increases Stake in Planet Labs PBC $PL

Aarti Pharmalabs Ltd leads gainers in 'A' group

Lyka Labs Share Price: मोठा दिलासा! कंपनी पहिल्यांदाच नफ्यात, पण एका उपकंपनीला विकणार?

Establishment Labs Holdings Inc (ESTA) Earnings Forecast: Future EPS & Revenue Growth Estimates

Shattuck Labs Inc (STTK) Earnings Forecast: Future EPS & Revenue Growth Estimates

Lyka Labs Posts 45% Revenue Growth, Approves Subsidiary Divestment

Lyka Labs: லாபம் **159%** உயர்வு! துணை நிறுவனத்தை விற்க அதிரடி முடிவு!

HALEOSLABS Standalone June 2026 Net Sales at Rs 67.83 crore, down 14.19% Y-o-Y

Aarti Pharmalabs shares hit 20% upper circuit as Q1 net profit surges 65% YoY to Rs 76 crore

Aarti Pharmalabs hits the roof after Q1 PAT rises 65% YoY

Quantum X Labs Pushes Into Nuclear Medicine as Share Price Stays Stuck in the Doldrums

Proto Labs’s Q2 Earnings Call: Our Top 5 Analyst Questions

Proto Labs's Q2 Earnings Call: Our Top 5 Analyst Questions Proto Labs' second quarter was marked by expanding relationships with large enterprise customers and robust growth in both Injection Molding and CNC Machining services. Management credited the company's focus on its four strategic pillars—elevating …

Is Planet Labs (PL) Turning Government AI Deals Into a Durable Edge in Geospatial Analytics?

Why Astera Labs (ALAB) Is Up 7.4% After Surging Q2 Results And Upbeat Q3 Guidance

Astera Labs (ALAB) saw its stock rise 7.4% following strong second-quarter 2026 results, reporting significant increases in sales and net income. The company also issued optimistic third-quarter 2026 guidance, projecting higher revenues and GAAP diluted EPS, driven by demand for AI and data center …

Por qué Astera Labs (ALAB) ha subido un 7,4 % tras publicar unos resultados del segundo trimestre muy positivos y unas previsiones optimistas para el tercer trimestre

Establishment Labs (ESTA) Stock Looks Fair On Cash Flow Yet Trades At A Premium On Sales

Aarti Pharmalabs Q1 Results: Consolidated revenue surges 118% YoY

Aarti Pharmalabs Publishes Q1 FY27 Financial Results in Newspapers

Proto Labs Inc (PRLB) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

VIVS PE Ratio & Valuation, Is VIVS Overvalued

The article provides a valuation analysis of VivoSim Labs Inc (VIVS), indicating that the stock is currently in the "Fair zone" based on its forward PS ratio. It details various financial metrics such as Price-to-Book (P/B) ratio, Free Cash Flow (FCF) yield, and compares …

Shattuck Labs, Inc. $STTK Stock Holdings Lifted by Renaissance Technologies LLC

Renaissance Technologies LLC significantly increased its stake in Shattuck Labs (NASDAQ:STTK) by 77.4% in Q1 2026, bringing its total holdings to 604,500 shares. Institutional investors and hedge funds collectively own 58.74% of the company's stock, while corporate insiders have recently sold shares totaling $591,850. …

Certain Common Stock of Shattuck Labs, Inc. are subject to a Lock-Up Agreement Ending on 9-AUG-2026.

Shattuck Labs, Inc. announced that certain common stocks are under a lock-up agreement ending on August 9, 2026. This lock-up period, starting from June 9, 2026, restricts directors and executive officers from selling these shares for 60 days without underwriter consent. The company, focused …

Astera Labs (ALAB) Posts Record Earnings, Is The Stock Now Too Expensive?

ESTABLISHMENT LABS HOLDINGS INC. 2026: Revenue $67.54M, EPS ($0.39) — 10-Q Summary

ESTABLISHMENT LABS HOLDINGS INC. reported strong financial results for 2026, with revenue increasing by 31.7% to $67.54M and net loss narrowing. The growth was primarily driven by expansion in the U.S. market and higher selling prices, with Motiva Implants gaining significant traction after FDA …

Is Planet Labs PBC (PL) Fully Valued After Its Scottish AI Data Deal?

Shareholders Can Be Confident That Proto Labs' (NYSE:PRLB) Earnings Are High Quality